Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Inside Geneva

Inside Geneva artwork

WHO candidate Hanan Balkhy: ‘The bottom line is that the funding is slimmer’

Oct 31, 202629 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Send us Fan Mail Inside Geneva has partnered with the Global Health Centre at the Geneva Graduate Institute to bring you exclusive interviews with the candidates for director general of the World Health Organization (WHO). Who wants to lead our top public health body? Hanan Balkhy is currently regional director for the WHO’s Eastern Mediterranean regional office, so she’s something of a WHO insider. A native of Saudi Arabia, she was educated in the United States and always wanted to be a doctor. Doing the WHO’s top job, she says, is a way “to serve the broader humanity.” She is especially concerned about antibiotic resistance, about the effects of climate change on health, and healthcare in conflict zones. She also warns about a “normalisation” of attacks on hospitals and healthcare workers. But she is also well aware that the WHO needs to reform and do more with less money. “The bottom line is that the funding is slimmer.” Listen to the full interview and subscribe to our Inside Geneva podcast. Get in touch! Email us at insidegeneva@swissinfo.ch Twitter: @ImogenFoulkes and @swissinfo_en Thank you for listening! If you like what we do, please leave a review or subscribe to our newsletter. For more stories on the international Geneva please visit www.swissinfo.ch/ Host: Imogen Foulkes Production assitant: Claire-Marie Germain Distribution: Sara Pasino Marketing: Xin Zhang

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

SPEAKER_03Hello and welcome to this special series from Inside Geneva. In partnership with Geneva Graduate Institute's Global Health Center and SwissInfo, I'm Imogen Folks.

SPEAKER_00Since 1948, thanks to the diversity and the commitment of its 194 member states, the World Health Organization has had a profound impact on improving the health of human beings around the world.

SPEAKER_05A vaccination campaign to combat the polio virus, which has re-emerged in Gaza for the first time in a quarter of a century, continued on Monday. The United Nations-led mission is working with Palestinian health authorities.

SPEAKER_03Supporting health services and tackling disease outbreaks in conflict zones.

SPEAKER_02Ebola keeps spreading in the east of Democratic Republic of Congo. It's moving so quickly. The World Health Organization adds, it's outpacing response efforts.

SPEAKER_03And advising on essential medicines.

SPEAKER_02Oh, that's a bad one.

SPEAKER_03Other member states are cutting their funding, and public health advice everywhere is being undermined by myths and disinformation. So who really wants to be the WHO's Director General? In this series, each episode brings you an in-depth, exclusive interview with a candidate for the job.

SPEAKER_03Today we hear from a woman who has long experience inside the WHO.

SPEAKER_04I'm very excited to be on this journey running for the Director General position for the World Health Organization, where I hope to serve the broader humanity. If you look at the phenomena of use and misuse of antibiotics, if you look at the impact of climate and how it has moved people and how it displaced people, and you look at wars, so all those things, these phenomena, require a highest level of leadership. What worries me most is the normalization, uh, the fear of normalization and supernormalization of attacks on healthcare.

SPEAKER_04I think there is a good place for improvement of our performance as the World Health Organization. And that needs to happen, whether we call it improving efficiency, reform. The bottom line is that the funding is slimmer.

SPEAKER_03But just before we start, some information about our editorial process. Geneva's prestigious graduate institute has invited all the candidates for an interview. We have key questions about global health challenges and about leading the WHO, which all candidates are asked. And some individual questions, because of course we want to get to know them not just as health leaders, but as people too. And the order in which our episodes appear has no significance.

SPEAKER_03It's simply related to which candidate found time for us when during their very busy schedules. So let's meet today's candidate.

SPEAKER_04My name is Hanan Balki. I'm a Saudi Arabian pediatrician, infectious disease subspecialist, but I'm a global public health servant at the moment. My current job is the regional director of the Eastern Mediterranean Region for the World Health Organization. And before that, I was in Geneva for five years as the assistant director general. And right now I'm very excited to be on this journey running for the Director General position for the World Health Organization, where I hope to serve uh the broader uh humanity.

SPEAKER_04So I'm very excited about this.

SPEAKER_03Well, we're gonna come on to your ambitions in a moment, but let's start with the past. I'm interested in what your childhood was like and how it led you to the to the career in health that you have now.

SPEAKER_04Well, I don't think you'll believe this, but this is the truth that I'm gonna tell you. So I'm the youngest of three children, and my both my parents uh are from the holy city of Mecca, so from Saudi Arabia. And my mom grew up at a time where there was not really any formal education, so she was home educated. She uh took care of the whole family and turned three of her family members, her husband and her three children, into doctors. So my mom is just an absolute phenomenal lady who uh supported us, and I'm the youngest of two physicians of three physicians.

SPEAKER_04And the reason why I became a doctor also it was because as the young child, I always wanted to be part of what my two older siblings were doing. So when they both went into medical school, I told them, you guys just leave me no choice. I can't choose anything else. I just felt it was imposed on me. And then I fell in love with the with with the work, and I'm still close to my siblings. So I think that was the major agenda for me.

SPEAKER_03You never thought of doing anything else. You really love it then.

SPEAKER_04Yes, indeed.

SPEAKER_03So let's look then at some of the things that you have focused on in your career in public health so far. One thing that I as a journalist have also looked a lot at in recent years is antimicrobial resistance, our growing resistance to what 80, 100 years ago were lifesavers, antibiotics. This is a big concern for you, I think.

SPEAKER_04Absolutely. I think when I specialized as a pediatrician, of course, a lot of what a general pediatrician would see as the common infections, a cough, an ear infection, a diarrhea. So antibiotics prescription is part of our routine training in pediatrics to start with. Then I became an infectious disease specialist where I was also still focused on treating the patient. So what does the patient have? You identify, you diagnose, and then you treat. By coincidence, my mentor, God bless him, Phil Toltsis, he was at Case Western, he was leading the infection control department at Case.

SPEAKER_04And he said, You need to come with me to this committee. And I, you know, as a trainee, I was still not aware what infection or hospital epidemiology and hospital infection control meant. So we went there and we sat with a brilliant group of nurses who led infection control at the hospital under uh Dr. Toltis' leadership. And then I like, that's interesting. We're seeing now a whole uh the holistic picture of what infection control and antimicrobial resistance impact on healthcare, the cost of healthcare provision, the outcomes of the patients.

SPEAKER_04And that was literally in 1996. Since then, I had a big passion in understanding more about antimicrobial resistance, and uh I continue to have a big passion on it. So you need to guide me for the next questions, otherwise, I can talk for another hour.

SPEAKER_03Well, one of the things I'm trying to get is that antimicrobial resistance is something the World Health Organization has been warning about. It may be something that you feel member states are not paying enough attention to. Another one that I know you focus on is climate change and health. So you said let's talk about something else. We talked about AMR. What about climate change and health?

SPEAKER_04So let me link the two together and I'll link it with another, which I call them, phenomena. So I look at antimicrobial resistance as a phenomena, exactly like climate and severe weather and climate change. And then there's a third piece that comes together that also feeds into AMR, if you want to make it the underpinning of the discussion for a bit, which is wars. So if you look at the phenomena of use and misuse of antibiotics, if you look at the impact of climate and how it has moved people and how is it displaced people, and you look at wars, which, as you know, I lead the Eastern Mediterranean region that has the largest numbers of conflicts and displaced populations, people living in destroyed environments or in tents that does not secure the basic needs on borders between countries, all of that feeds into poor hygiene and the bacteria specifically, but other types of pathogens as well, building capacity to resist treatments.

SPEAKER_04Number one, number two, the easy spread between people and population, and the lack of ability for easy access. So, all those things, these phenomena, require a highest level of leadership. And that's where we have succeeded in WHO to bring the antimicrobial resistance agenda to the highest level. And what I would do as the next DG, which what I'm also doing as a regional director, is to focus at the country level what needs to change and how can we support them in making some of those plans a reality and not just a document sitting somewhere?

SPEAKER_03Which happens unfortunately so often with the best of uh member state intentions. You mentioned conflict. You are, as you said, Eastern Mediterranean. Of course, that includes Gaza. What could you do as the new leader of the World Health Organization to encourage more respect for the fact that health workers are protected or should be protected in conflict zones and not killed? And that essential medical care, that's medicines, as well as the workers, should be allowed to move freely.

SPEAKER_03Because we know the World Health Organization has said it many times officially, this has not been happening in the conflict in Gaza, actually hasn't been happening in the conflict in Sudan either.

SPEAKER_04I think conflicts are not new either. So conflicts around the world have been taking place. But what worries me most, and I think most of us in the public health arenas and within the different UN agencies, is the normalization, uh, the fear of normalization and supernormalization of attacks on healthcare. It was about 10 years ago where we got the mandate from the member states to report and to advocate on the security of the healthcare. Healthcare includes healthcare facilities, health workforce, warehouses, ambulances, that they should be secured from any types of conflicts.

SPEAKER_04I think any director general has the responsibility to continue to move forward with that agenda and to work with other UN entities that have different mandates to support this agenda. I think the minimum that can happen is, again, as much as you would want to say that it's ethically not acceptable to attack healthcare facilities, it's also important that we show the impact. If you look at the impact of wars in Gaza specifically, there's a growing evidence and literature and research showing how the impact on the infrastructure number one and the lack of proper health care and access for the people has led to a significant rise in antimicrobial resistance.

SPEAKER_04But that's just one indicator. But all types of other diseases. The impact of the destruction on the resurgence after 25 years of paralytic polio. We can talk about that for a few minutes and what the WHO and partners did to stop further spread, which really saved the world from a virus that's almost uh eradicated.

SPEAKER_03This is true. I remember reporting on that out of Geneva at the time. And absolutely, I mean, we should remind our listeners amazing effort the WHO made in Gaza to get children vaccinated. I'm gonna come on to a different topic, though. Whoever leads the World Health Organization next has got multiple challenges. Let's look at a couple. The world superpower of the United States has left. How are you gonna fill that both the political motivational gap and the funding?

SPEAKER_03Or would you try and and try and hug the US close and bring them back?

SPEAKER_04I think any director general, again, I'll speak in general, but for myself, it would be a tough agenda to communicate with the U United States of America to better understand what else can be done. I have to admit that some of the comments on the UN by the US and other member states, I do agree with. I think there is a good place for improvement of our performance as the World Health Organization and as the UN agencies together in their mandates, in their mitigating or minimizing, sorry, overlaps.

SPEAKER_04So there's a lot of work that can be done to improve the performance of the UN system and the WHO itself. And that needs to happen, whether we call it improving efficiency, reform. The bottom line is that the funding is slimmer. And because of that, you always have to recalibrate what needs to take place. And as a regional director, I came in as regional director before the US withdrew, and I immediately looked at our efficiencies in the region.

SPEAKER_04So I immediately, for example, I stopped hiring, I kept all of those vacant positions that I received. I kept them and I froze them. And I said, until I understand who's doing what and at what efficiency level, we're not hiring any new people, except, of course, for the critical positions. I froze, I would say, if I remember, maybe 40, 50 positions. The other thing that I did is I eliminated all of the redundant workshops, which at one point was seen as necessary.

SPEAKER_04But I said, let's recalibrate again and let's look at what exactly do the member states need and how are how are we going to prioritize. So that saved us a good amount of funding in the Eastern Mediterranean. So back to to answer specifically on the US, there needs to continue to have, I will definitely have efforts in bringing the US back, open the discussions, have a dialogue, and better understand whether there are things that need to be addressed or not.

SPEAKER_03You said that some of the things that the US and other member states, you qualified it, said you agree with this is about not making the WHO more efficient, not having it duplicate with other agencies. I just need to pick you up on something though. Some of the things that we are hearing from the United States and from the administration, some people might call them misinformation about vaccines, for example. How can you tackle that?

SPEAKER_04So the misinformation on vaccines for any of us who has worked in in infectious disease public health, our whole lives is about the toe and fro between the understanding of science related to infectious diseases, small outbreaks or big outbreaks, and vaccines specifically is one of them. As you you you you can see every flu season, we get pushback even from physicians about the effectiveness of vaccines. I think one the best way to work around that and to work with that, because that is a challenge that is not going to go away.

SPEAKER_04And you're always gonna have people who trust the science, people who do not trust the science. I think the WHO needs to do several things, and that's where my platform talks about trust, impact, and value. And the first pillar of my platform, which speaks about trust, where I want to work more on the transparency of the guideline development, more engagement in science generation. Many member states have very clearly said that we don't see ourselves in the science.

SPEAKER_04The clinical trials are done elsewhere, we're not included. So that transparency and inclusion that the member states are asking for needs to be addressed. Then there needs to be a stronger working alignment between the WHO, which is the global body of science of guideline development and production of health uh notions, if you will, with the national public health authorities. Because the population, they're not just sometimes mistrusting WHO, many times they're mistrusting their own public health uh agencies, and sometimes they're mistrusting their physicians.

SPEAKER_04So that alignment, when we all speak the same language and we trust that what we're saying is based on science, it will create a stronger alignment between science and those who are, if you want to call them anti-science or non-believers, that it can work better. There is a large body of work that needs to take place, and there's a large body of understanding that needs to take place on the new modalities of communication. It's not an easy, it's not an easy question that you're asking.

SPEAKER_03Certainly not nowadays, with all of the, you know, we have this flood of information, some of it on very unregulated platforms. We had the COVID-19 pandemic that seemed to fuel mistrust and fear, understandably, in some ways. But we're now in this limbo regarding a pandemic treaty, which the WHO has urged member states to get on board with. Where do you stand on that?

SPEAKER_04I think the pandemic treaty is trying to address a very, again, a very tough question. And as you know, part of the pandemic treaty was approved in 2025. Now we're left with the pathogen access and benefit sharing, which is the critical part. That's the linchpin of the whole pandemic treaty, if you will, because member states need to share the pathogen, and member states want to benefit from the outcome and the output of science and innovation and industry. And I think it's a fair request from both sides because innovation and securing the continuous innovation is very important.

SPEAKER_04But also, if people do not benefit, then the value to the human beings becomes less visible to everyone. So the WHO has a role, and we're doing our utmost best even before going on leave. For me, as a public health servant and what we've seen and noticed during the pandemic, it is important that the world and the people in general see that there will be equity. I want to say better equity, but that's not satisfactory enough.

SPEAKER_04There needs to be equity, and we need to strive to the highest level of equity possible. But uh, if we do not reach an agreement, there will be no equity. Again, we'll go back to square zero on the sharing where you saw around 10% of some of the regions getting their first vaccine. One of the member states, by the way, uh emoji I met during this campaign so far, told me that her country has still not received one COVID vaccine. Not one. They have none in their stock. They received nothing.

SPEAKER_04So I think those realities are difficult to argue against. So we will do our, you know, so whether it's me as a regional director, uh, if I do become the director general, it will be, and it's not completed yet, it will be a big priority to figure out how do we work with this inequity on the benefit sharing.

SPEAKER_03You brought me actually to my next broader question. I've asked you about specifics, about vaccines, about antimicrobial resistance, health inequity. You brought it up yourself. Does it dismay you that here we are in 2026 and you're still seeing this huge gap between the wealthy countries and the least developed ones?

SPEAKER_04It's heartbreaking for me. It is absolutely heartbreaking. During my time as regional director, I've been to all 22 member states, but one. I've been to Gaza during the war, I've been in Afghanistan, I've been in every single one except for one, as I said. So I've seen it all. I've seen the camps, I've seen the displaced, I've seen destroyed hospitals, I've seen countries coming out of conflict, countries under sanctions. And the inequity is uh really heartbreaking.

SPEAKER_04As a WHO leader, I'm laser focused on really solving the access problem. And that can only be done by not by guidelines, but working with the member states on securing local production, securing their national regulatory authorities, securing a system and not just WHO, WHO and partners on establishing the warehouses, digitalization, sharing of uh basic uh essential medicine list uh products. Um that's one part.

SPEAKER_04We already spoke about the issue of peace and and lack of you know, getting rid of the conflicts that target healthcare facilities, and then working on the financial aspects of healthcare provision. So those are like some of the pieces that come under my value pillar, and the value goes back. Back to access for everybody. So everything that we do in WHO has to be built on trust, has to be driven by the impact on the ground, and has to be measured by the value it gives to the people, which is mitigating and closing those gaps on inequity.

SPEAKER_03You've dedicated your life to public health. That's clear. You're clearly passionate about it. But um, what do you like to do when you're not doing that?

SPEAKER_04I like to go and see what my kids are doing and haunt them a little bit. No, but seriously, I'm a very family-oriented person. I'm very attached to my family. I have uh an amazing loving husband who supports me to the extreme, and two loving boys. And I'm very blessed that both my parents are still alive. And uh, my biggest joy is really to spend family time hiking. Sometimes I cook, but not too much.

SPEAKER_03Hard to find the time at the moment, I imagine. Okay. Last question, and this is for the listeners out there who maybe know what WHO stands for, but not so much about it and have maybe read some misinformed headlines here and there. Why do we need the World Health Organization? And why do we need you to lead it?

SPEAKER_04So the WHO is a multilateral organization. I think it has the largest number of membership among many of the other uh UN agencies. One of its biggest agendas is, of course, to bring member states together on a unified understanding of health. That's number one. Number two, it has parts of the work that we do deals with global health security. And the global health security agenda is a shared agenda. Uh exactly as you said, not one country can do it alone.

SPEAKER_04And the reason why, in some of the countries, as you mentioned, like in Switzerland or Europe or very advanced countries, a lot of the mitigation that is happening, you would not hear about. If you realize that we get in the WHO hundreds of signals of outbreaks a day that are managed and mitigated and stopped, but you don't know about them. People will not know about this daily work that we do. However, you do hear about the pandemics, you hear about what's happening in DRC and now in and what happened in Uganda, and thank God that was closed.

SPEAKER_04And now we have a case in Kenya. So all of that amazing work that the WHO leads with partners to secure the early detection of diseases and stopping its spread early on is the luxury that many countries and people live in, but they they they don't realize it. And that's the whole essence of preventive medicine. So when things are prevented, you do not hear about it, you're not aware of it. And at the same time, when they do happen, we are pointed at, which is the the name of the game, if you will.

SPEAKER_04The other areas of work that WHO, because it's very difficult to simplify the work in one or two words. So we talked about the multilateralism part, we talked about um mitigation of outbreaks and infections, but also in developing guidelines and producing pre-qualification for countries that do not have the capacity to do so. So if you're a high-income country, if you're the United States or if you're okay or Germany, you can produce your own science and produce your own treatment guidelines.

SPEAKER_04Many member states don't have that luxury. So the WHO has the capacity to convene, and that's another key word for our work. We convene for science guideline development, and we also produce and support member states and help them with identifying something called the Essentials Medicines list. So if a member state needs to establish their own healthcare ecosystem and they need to identify which drugs should they get and from where and what are the treatment guidelines, they can rely on a body like the WHO.

SPEAKER_04The other thing that WHO does, it secures the safety and the quality of the medications that the people consume. Because many member states also cannot do that. So the WHO deals with almost every aspect of health in one way or another. So we have a huge body of work that we do, and personally, I do not see the world without the WHO. Why do you need me as the director general for the WHO? Because I'm a hybrid candidate.

SPEAKER_04I've worked outside of the organization for most of my career. Uh, you know, I'm a full professor, I'm a scientist, uh, I led regional and global entities before joining the WHO. I worked for the WHO for at least 12 years before joining it. I had a WHO collaborating center. I know it from outside. I know what the things that I was not happy with as an outsider. And as an internal leader within the WHO, I led and I built an entity in a headquarters, which is the AMR division.

SPEAKER_04And I was elected into my current position. So I know the organization at all three levels and as an outsider. I know the areas that require reform immediately, and I will not be shy, nor will I have to ask a whole lot of questions. I will be listening. I don't want to scare the internal staff. I will be listening still, but uh I already know a lot about the organization and where it needs to go at this moment. And I'm very willing to do this extremely, extremely difficult and challenging job.

SPEAKER_04It's not going to be easy. It's not going to be easy for anybody, but I think it's much necessary, and the WHO has a lot, a lot to offer for the world.

SPEAKER_03And that brings us to the end of this episode of our special series on the campaign to lead the WHO. The series is a co-production from the Global Health Centre of Geneva's Graduate Institute and SwissInfo. Tune in wherever you get your podcasts for our future episodes, where we'll be talking to more candidates to be Director General. And for more information about the WHO and its possible leaders, take a look at the Global Health Centre's dedicated platform by going to gh platform.org forward slash WHO dash dg-election.

SPEAKER_03I'm Imogen folks, thanks for listening.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. UN Secretary-General: who wants the world's toughest job?

    Nov 10, 202632 minAudio

    Send us Fan Mail This week on Inside Geneva, host Imogen Foulkes looks at the race to become the next UN Secretary-General. Antonio Guterres will step down in just six weeks, but the UN Security Council cannot agree on...

    Credit the people on this episode

  2. WHO candidate Gevorg Tamamyan: ‘Geography must not decide who lives’

    Nov 8, 202629 minAudio

    Send us Fan Mail In episode four of our series interviewing candidates for director general of the World Health Organization (WHO), we talk to Gevorg Tamamyan. This series is in partnership with the Global Health Centre...

    Credit the people on this episode

  3. WHO candidate Maria Neira: ‘We need to rebuild credibility and trust.’

    Nov 7, 202629 minAudio

    Send us Fan Mail Inside Geneva has partnered with the Global Health Centre at the Geneva Graduate Institute to bring you exclusive interviews with the candidates for director general of the World Health Organization...

    Credit the people on this episode

  4. WHO candidate Budi Sadikin: no country can fight a pandemic alone

    Nov 1, 202628 minAudio

    Send us Fan Mail Here is episode two of our series in partnership with the Global Health Centre at the Geneva Graduate Institute, bringing you exclusive interviews with the candidates for director general of the World...

    Credit the people on this episode

  5. Who will defend the International Criminal Court?

    Oct 27, 202641 minAudio

    Send us Fan Mail This week on Inside Geneva, host Imogen Foulkes asks whether the International Criminal Court (ICC) can survive Washington’s brutal sanctions. James Goldston of Open Society tells us the sanctions mean...

    Credit the people on this episode